| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $917,927 ) |
| | 2025 | 2025 | RISSANA LLC | 9 N EUCLID AVE | SAINT LOUIS | MO | 63108-1482 | SAINT LOUIS CITY | USA | R44DA055161 | A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder | 001 | 2 | NIH | 12/3/2024 | $917,927 |
| | 2025 | 2022 | RISSANA LLC | 9 N EUCLID AVE | SAINT LOUIS | MO | 63108-1482 | SAINT LOUIS CITY | USA | R44DA055161 | A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder | 000 | 1 | NIH | 12/3/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | RISSANA LLC | 9 N EUCLID AVE | SAINT LOUIS | MO | 63108-1482 | SAINT LOUIS CITY | USA | R44DA055161 | A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder | 000 | 1 | NIH | 8/21/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $253,447 ) |
| | 2022 | 2022 | RISSANA, LLC | 327 N TAYLOR AVE APT 107 | SAINT LOUIS | MO | 63108-1969 | SAINT LOUIS CITY | USA | R44DA055161 | A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder | 000 | 1 | NIH | 8/29/2022 | $253,447 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | RISSANA, LLC | 327 N TAYLOR AVE APT 107 | SAINT LOUIS | MO | 63108-1969 | SAINT LOUIS CITY | USA | R41DA050232 | A mobile technology to extend the reach of primary care for opioid misuse | 000 | 1 | NIH | 2/12/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | RISSANA, LLC | 327 N TAYLOR AVE APT 107 | SAINT LOUIS | MO | 63108-1969 | SAINT LOUIS CITY | USA | R41DA050232 | A mobile technology to extend the reach of primary care for opioid misuse | 000 | 1 | NIH | 11/6/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $209,892 ) |
| | 2019 | 2019 | RISSANA, LLC | 327 N TAYLOR AVE APT 107 | SAINT LOUIS | MO | 63108-1969 | SAINT LOUIS CITY | USA | R41DA050232 | A mobile technology to extend the reach of primary care for opioid misuse | 000 | 1 | NIH | 9/26/2019 | $209,892 |
|
|
